1,317 reports of this reaction
3.7% of all THEOPHYLLINE reports
#3 most reported adverse reaction
PNEUMONIA is the #3 most commonly reported adverse reaction for THEOPHYLLINE, manufactured by Rhodes Pharmaceuticals L.P.. There are 1,317 FDA adverse event reports linking THEOPHYLLINE to PNEUMONIA. This represents approximately 3.7% of all 35,594 adverse event reports for this drug.
Patients taking THEOPHYLLINE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is moderately reported among THEOPHYLLINE users, representing a notable but not dominant share of adverse events.
In addition to pneumonia, the following adverse reactions have been reported for THEOPHYLLINE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 1,317 FDA reports for THEOPHYLLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 3.7% of all adverse event reports for THEOPHYLLINE, making it one of the most commonly reported side effect.
If you experience pneumonia while taking THEOPHYLLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.